InvestorsHub Logo
Followers 92
Posts 11421
Boards Moderated 0
Alias Born 06/06/2014

Re: frrol post# 391261

Friday, 12/09/2022 11:14:14 PM

Friday, December 09, 2022 11:14:14 PM

Post# of 467011
Should add, the author endorses lecanemab as likely to be approved, but did not mention safety (for our drug or Biogen's). To be fair, he also did not mention tolerability and dosing titration.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News